SCHEMBL7557595

SCHEMBL7557595

COc1cccc2c1[nH]c(=O)n2CCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.69
ABCB11 O95342 1/20 0.69
ADRA2A P08913 1/20 0.69
ADORA3 P0DMS8 1/20 0.69
CHRM1 P11229 1/20 0.69
DRD1 P21728 1/20 0.69
TBXA2R P21731 1/20 0.69
SLC6A4 P31645 1/20 0.69
ADRA1A P35348 1/20 0.69
OPRM1 P35372 1/20 0.69
DRD3 P35462 1/20 0.69
KCNH2 Q12809 1/20 0.69
TSHR P16473 3/20 0.56
KDM4E B2RXH2 1/20 0.56
ALOX15 P16050 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
MAPT P10636 3/20 0.53
TP53 P04637 1/20 0.52
HTR7 P34969 2/20 0.52
LMNA P02545 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12319122 0.87 HTR1A (0.65) HTR1AABCB11ADRA2AADORA3CHRM1
SCHEMBL6606801 0.85 HTR1A (0.73) HTR1AABCB11ADRA2AADORA3CHRM1
SCHEMBL7551972 0.85 HTR1A (0.69) HTR1AABCB11ADRA2AADORA3CHRM1
SCHEMBL7587470 0.82 HTR1A (0.74) HTR1AABCB11ADRA2AADORA3CHRM1
SCHEMBL6606413 0.82 HTR1A (0.74) HTR1AABCB11ADRA2AADORA3CHRM1
Flibanserin SCHEMBL247579 0.82 HTR1A (1.00) HTR1AABCB11ADRA2AADORA3CHRM1
Flibanserin SCHEMBL29399513 0.82 HTR1A (1.00) HTR1AABCB11ADRA2AADORA3CHRM1
Flibanserin SCHEMBL30249132 0.82 HTR1A (1.00) HTR1AABCB11ADRA2AADORA3CHRM1
Flibanserin SCHEMBL19743151 0.81 HTR1A (0.98) HTR1AABCB11ADRA2AADORA3CHRM1
Flibanserin SCHEMBL2526226 0.81 HTR1A (0.98) HTR1AABCB11ADRA2AADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218352-A1 BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) 2002-07-03 EP disclosed
US-6281218-B1 USEFUL IN THE TREATMENT OF CNS DISORDERS. INGELHEIM ITALIA S.P.A. (IT) 2001-08-28 US disclosed
WO-2001021593-A1 NEW BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) 2001-03-29 WO disclosed